Conquering Diseases

Investigational Drug Study For Patients With Rheumatoid Arthritis


Seeking Men and Women 18 years or older who have completed a Gilead sponsored filgotinib parent study for RA GS-US-417-0303 for the treatment of Rheumatoid Arthritis (RA),


The purpose of this study is to see if filgotinib (study drug) can be safe and useful in the long-term treatment of Rheumatoid Arthritis.

What we're hoping for

The results and information obtained from this study may help others in the future.

Additional Information Identifier: NCT03025308

 Principal Investigator

Jonathan  Kay, MD

UMass Memorial Health Care

 Study Contact

Steven  Ball



UMMHC Memorial Campus

281 Lincoln St. 

Worcester,MA 01605